Fast and Simultaneous Analysis of Ethanol Metabolites and Barbiturates

Feb 16, 2017 | Blogs, Forensic | 0 comments

While most analytes in forensic applications analyze well with positive ionization, there are analytes that show better ionization efficiency with negative ionization, for example, acidic compounds. These analytes include ethanol metabolites such as ethyl glucuronide (ETG), ethyl sulfate (ETS), and the barbiturates such as amobarbital, butabarbital, butalbital, pentobarbital, phenobarbital, and secobarbital.

 

In this technical note, researchers demonstrated a method to simultaneously analyze ethanol metabolites and barbiturates in human urine using QTRAP®/Triple Quad 4500 LC-MS/MS system. Sample preparation is based on a simple “dilute and shoot” methodology. The method has a total runtime of 5 minutes, shows good sensitivity and is very robust. More than 800 continuous injections of human urine samples were performed on a single LC column with no deterioration in performance evident.

How does this test play out in real-world scenarios? ETG and ETS are biomarkers for determining the presence of alcohol over the past 80 hours where ETG is the direct metabolite of alcohol. ETG is only detected if alcohol has been consumed. What is more is that urine tests are the most common and inexpensive choice when testing for drug use and can be easily captured. Making sure results stand up in court, but also being able to run simultaneous drug screenings will help your lab keep up with sample workloads while also producing reliable results.

PFAS testing: 2024 in review and what to expect for 2025

For as long as PFAS persist in the environment, there is no doubt they will persist in our conversations as environmental scientists. Globally, PFAS contamination has been detected in water supplies, soil and even in the blood of people and wildlife. Different countries are at various stages of addressing PFAS contamination and many governments have set regulatory limits and are working on assessing the extent of contamination, cleaning up affected sites and researching safer alternatives.

Inside the box: Acoustic ejection mass spectrometry for drug discovery

On average, it takes 10-15 years and 1-2 billion dollars to approve a new pharmaceutical for clinical use. Since approximately 90% of new drug candidates fail in clinical development, the ability to make early, informed and accurate decisions on the safety and efficacy of new hits and leads is key to increasing the chances of success.

Unveiling the power of ZT Scan DIA: Insights from Ludwig Sinn’s presentation at World HUPO Congress 2024

In a recent presentation at the World HUPO Congress 2024, Ludwig Sinn from the Ralser lab shared exciting advancements in proteomics research, focusing on the innovative ZT Scan DIA acquisition modes developed in collaboration with SCIEX. Let us explore the key highlights and benefits of this innovative technology.

Posted by

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial